Europe Peptide Therapeutics Market Report 2016

November 2016 | 114 pages | ID: E4B806D445FEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Peptide Therapeutics

Revenue, means the sales value of Peptide Therapeutics

This report studies sales (consumption) of Peptide Therapeutics in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Amgen
• Roche
• Sanofi
• Takeda Pharmaceutical
• Lonza
• Novartis
• AstraZeneca
• Bachem
• CordenPharma
• Eli Lilly
• Ipsen
• Merck
• Novo Nordisk
• PolyPeptide Group
• Teva

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Peptide Therapeutics in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Generic Peptide Therapeutics
• Branded Peptide Therapeutics
• Type III

Split by application, this report focuses on sales, market share and growth rate of Peptide Therapeutics in each application, can be divided into

• Cancer
• Cardiovascular
• Central Nervous System
• Metabolic Disorders
• Infection
• Hematological Disorders
• Gastrointestinal Disorders
• Respiratory Disorders
• Acromegaly
• Other Applications

Contents

Europe Peptide Therapeutics Market Report 2016

1 PEPTIDE THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics
  1.2.1 Generic Peptide Therapeutics
  1.2.2 Branded Peptide Therapeutics
  1.2.3 Type III
1.3 Application of Peptide Therapeutics
  1.3.1 Cancer
  1.3.2 Cardiovascular
  1.3.3 Central Nervous System
  1.3.4 Metabolic Disorders
  1.3.5 Infection
  1.3.6 Hematological Disorders
  1.3.7 Gastrointestinal Disorders
  1.3.9 Respiratory Disorders
  1.3.9 Acromegaly
  1.3.10 Other Applications
1.4 Peptide Therapeutics Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Peptide Therapeutics (2011-2021)
  1.5.1 Europe Peptide Therapeutics Sales and Growth Rate (2011-2021)
  1.5.2 Europe Peptide Therapeutics Revenue and Growth Rate (2011-2021)

2 EUROPE PEPTIDE THERAPEUTICS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Peptide Therapeutics Market Competition by Manufacturers
  2.1.1 Europe Peptide Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Peptide Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Peptide Therapeutics (Volume and Value) by Type
  2.2.1 Europe Peptide Therapeutics Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Peptide Therapeutics Revenue and Market Share by Type (2011-2016)
2.3 Europe Peptide Therapeutics (Volume and Value) by Countries
  2.3.1 Europe Peptide Therapeutics Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Peptide Therapeutics Revenue and Market Share by Countries (2011-2016)
2.4 Europe Peptide Therapeutics (Volume) by Application

3 GERMANY PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Peptide Therapeutics Sales and Value (2011-2016)
  3.1.1 Germany Peptide Therapeutics Sales and Growth Rate (2011-2016)
  3.1.2 Germany Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Peptide Therapeutics Sales Price Trend (2011-2016)
3.2 Germany Peptide Therapeutics Sales and Market Share by Manufacturers
3.3 Germany Peptide Therapeutics Sales and Market Share by Type
3.4 Germany Peptide Therapeutics Sales and Market Share by Application

4 FRANCE PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

4.1 France Peptide Therapeutics Sales and Value (2011-2016)
  4.1.1 France Peptide Therapeutics Sales and Growth Rate (2011-2016)
  4.1.2 France Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  4.1.4 France Peptide Therapeutics Sales Price Trend (2011-2016)
4.2 France Peptide Therapeutics Sales and Market Share by Manufacturers
4.3 France Peptide Therapeutics Sales and Market Share by Type
4.4 France Peptide Therapeutics Sales and Market Share by Application

5 UK PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Peptide Therapeutics Sales and Value (2011-2016)
  5.1.1 UK Peptide Therapeutics Sales and Growth Rate (2011-2016)
  5.1.2 UK Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  5.1.5 UK Peptide Therapeutics Sales Price Trend (2011-2016)
5.2 UK Peptide Therapeutics Sales and Market Share by Manufacturers
5.3 UK Peptide Therapeutics Sales and Market Share by Type
5.4 UK Peptide Therapeutics Sales and Market Share by Application

6 RUSSIA PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Peptide Therapeutics Sales and Value (2011-2016)
  6.1.1 Russia Peptide Therapeutics Sales and Growth Rate (2011-2016)
  6.1.2 Russia Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Peptide Therapeutics Sales Price Trend (2011-2016)
6.2 Russia Peptide Therapeutics Sales and Market Share by Manufacturers
6.3 Russia Peptide Therapeutics Sales and Market Share by Type
6.4 Russia Peptide Therapeutics Sales and Market Share by Application

7 ITALY PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Peptide Therapeutics Sales and Value (2011-2016)
  7.1.1 Italy Peptide Therapeutics Sales and Growth Rate (2011-2016)
  7.1.2 Italy Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Peptide Therapeutics Sales Price Trend (2011-2016)
7.2 Italy Peptide Therapeutics Sales and Market Share by Manufacturers
7.3 Italy Peptide Therapeutics Sales and Market Share by Type
7.4 Italy Peptide Therapeutics Sales and Market Share by Application

8 SPAIN PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Peptide Therapeutics Sales and Value (2011-2016)
  8.1.1 Spain Peptide Therapeutics Sales and Growth Rate (2011-2016)
  8.1.2 Spain Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Peptide Therapeutics Sales Price Trend (2011-2016)
8.2 Spain Peptide Therapeutics Sales and Market Share by Manufacturers
8.3 Spain Peptide Therapeutics Sales and Market Share by Type
8.4 Spain Peptide Therapeutics Sales and Market Share by Application

9 BENELUX PEPTIDE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Peptide Therapeutics Sales and Value (2011-2016)
  9.1.1 Benelux Peptide Therapeutics Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Peptide Therapeutics Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Peptide Therapeutics Sales Price Trend (2011-2016)
9.2 Benelux Peptide Therapeutics Sales and Market Share by Manufacturers
9.3 Benelux Peptide Therapeutics Sales and Market Share by Type
9.4 Benelux Peptide Therapeutics Sales and Market Share by Application

10 EUROPE PEPTIDE THERAPEUTICS MANUFACTURERS ANALYSIS

10.1 Amgen
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Peptide Therapeutics Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Amgen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Peptide Therapeutics Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Roche Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Sanofi
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Peptide Therapeutics Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Takeda Pharmaceutical
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Peptide Therapeutics Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Takeda Pharmaceutical Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Lonza
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Peptide Therapeutics Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Lonza Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Novartis
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Peptide Therapeutics Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 AstraZeneca
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Peptide Therapeutics Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Bachem
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Peptide Therapeutics Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Bachem Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 CordenPharma
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Peptide Therapeutics Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 CordenPharma Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Eli Lilly
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Peptide Therapeutics Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Ipsen
10.12 Merck
10.13 Novo Nordisk
10.14 PolyPeptide Group
10.15 Teva

11 PEPTIDE THERAPEUTICS MANUFACTURING COST ANALYSIS

11.1 Peptide Therapeutics Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Peptide Therapeutics

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Peptide Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE PEPTIDE THERAPEUTICS MARKET FORECAST (2016-2021)

14.1 Germany Peptide Therapeutics Sales Forecast (2016-2021)
14.2 France Peptide Therapeutics Sales Forecast (2016-2021)
14.3 UK Peptide Therapeutics Sales Forecast (2016-2021)
14.4 Russia Peptide Therapeutics Sales Forecast (2016-2021)
14.5 Italy Peptide Therapeutics Sales Forecast (2016-2021)
14.6 Spain Peptide Therapeutics Sales Forecast (2016-2021)
14.7 Benelux Peptide Therapeutics Sales Forecast (2016-2021)
14.8 Europe Peptide Therapeutics Sales Forecast by Type (2016-2021)
14.9 Europe Peptide Therapeutics Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Peptide Therapeutics
Table Classification of Peptide Therapeutics
Figure Europe Sales Market Share of Peptide Therapeutics by Type in 2015
Figure Generic Peptide Therapeutics Picture
Figure Branded Peptide Therapeutics Picture
Table Application of Peptide Therapeutics
Figure Europe Sales Market Share of Peptide Therapeutics by Application in 2015
Figure Cancer Examples
Figure Cardiovascular Examples
Figure Central Nervous System Examples
Figure Metabolic Disorders Examples
Figure Infection Examples
Figure Hematological Disorders Examples
Figure Gastrointestinal Disorders Examples
Figure Respiratory Disorders Examples
Figure Acromegaly Examples
Figure Other Applications Examples
Figure Germany Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure France Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure UK Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure Russia Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure Italy Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure Spain Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure Benelux Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Peptide Therapeutics Sales and Growth Rate (2011-2021)
Figure Europe Peptide Therapeutics Revenue and Growth Rate (2011-2021)
Table Europe Peptide Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table Europe Peptide Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Peptide Therapeutics Sales Share by Manufacturers
Figure 2016 Peptide Therapeutics Sales Share by Manufacturers
Table Europe Peptide Therapeutics Revenue by Manufacturers (2015 and 2016)
Table Europe Peptide Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Peptide Therapeutics Revenue Share by Manufacturers
Table 2016 Europe Peptide Therapeutics Revenue Share by Manufacturers
Table Europe Peptide Therapeutics Sales and Market Share by Type (2011-2016)
Table Europe Peptide Therapeutics Sales Share by Type (2011-2016)
Figure Sales Market Share of Peptide Therapeutics by Type (2011-2016)
Figure Europe Peptide Therapeutics Sales Growth Rate by Type (2011-2016)
Table Europe Peptide Therapeutics Revenue and Market Share by Type (2011-2016)
Table Europe Peptide Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Peptide Therapeutics by Type (2011-2016)
Figure Europe Peptide Therapeutics Revenue Growth Rate by Type (2011-2016)
Table Europe Peptide Therapeutics Sales and Market Share by Countries (2011-2016)
Table Europe Peptide Therapeutics Sales Share by Countries (2011-2016)
Figure Sales Market Share of Peptide Therapeutics by Countries (2011-2016)
Table Europe Peptide Therapeutics Revenue and Market Share by Countries (2011-2016)
Table Europe Peptide Therapeutics Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Peptide Therapeutics by Countries (2011-2016)
Table Europe Peptide Therapeutics Sales and Market Share by Application (2011-2016)
Table Europe Peptide Therapeutics Sales Share by Application (2011-2016)
Figure Sales Market Share of Peptide Therapeutics by Application (2011-2016)
Figure Germany Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure Germany Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure Germany Peptide Therapeutics Sales Price Trend (2011-2016)
Table Germany Peptide Therapeutics Sales by Manufacturers (2015 and 2016)
Table Germany Peptide Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Germany Peptide Therapeutics Sales by Type (2015 and 2016)
Table Germany Peptide Therapeutics Market Share by Type (2015 and 2016)
Table Germany Peptide Therapeutics Sales by Application (2015 and 2016)
Table Germany Peptide Therapeutics Market Share by Application (2015 and 2016)
Figure France Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure France Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure France Peptide Therapeutics Sales Price Trend (2011-2016)
Table France Peptide Therapeutics Sales by Manufacturers (2015 and 2016)
Table France Peptide Therapeutics Market Share by Manufacturers (2015 and 2016)
Table France Peptide Therapeutics Sales by Type (2015 and 2016)
Table France Peptide Therapeutics Market Share by Type (2015 and 2016)
Table France Peptide Therapeutics Sales by Application (2015 and 2016)
Table France Peptide Therapeutics Market Share by Application (2015 and 2016)
Figure UK Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure UK Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure UK Peptide Therapeutics Sales Price Trend (2011-2016)
Table UK Peptide Therapeutics Sales by Manufacturers (2015 and 2016)
Table UK Peptide Therapeutics Market Share by Manufacturers (2015 and 2016)
Table UK Peptide Therapeutics Sales by Type (2015 and 2016)
Table UK Peptide Therapeutics Market Share by Type (2015 and 2016)
Table UK Peptide Therapeutics Sales by Application (2015 and 2016)
Table UK Peptide Therapeutics Market Share by Application (2015 and 2016)
Figure Russia Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure Russia Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure Russia Peptide Therapeutics Sales Price Trend (2011-2016)
Table Russia Peptide Therapeutics Sales by Manufacturers (2015 and 2016)
Table Russia Peptide Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Russia Peptide Therapeutics Sales by Type (2015 and 2016)
Table Russia Peptide Therapeutics Market Share by Type (2015 and 2016)
Table Russia Peptide Therapeutics Sales by Application (2015 and 2016)
Table Russia Peptide Therapeutics Market Share by Application (2015 and 2016)
Figure Italy Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure Italy Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure Italy Peptide Therapeutics Sales Price Trend (2011-2016)
Table Italy Peptide Therapeutics Sales by Manufacturers (2015 and 2016)
Table Italy Peptide Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Italy Peptide Therapeutics Sales by Type (2015 and 2016)
Table Italy Peptide Therapeutics Market Share by Type (2015 and 2016)
Table Italy Peptide Therapeutics Sales by Application (2015 and 2016)
Table Italy Peptide Therapeutics Market Share by Application (2015 and 2016)
Figure Spain Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure Spain Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure Spain Peptide Therapeutics Sales Price Trend (2011-2016)
Table Spain Peptide Therapeutics Sales by Manufacturers (2015 and 2016)
Table Spain Peptide Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Spain Peptide Therapeutics Sales by Type (2015 and 2016)
Table Spain Peptide Therapeutics Market Share by Type (2015 and 2016)
Table Spain Peptide Therapeutics Sales by Application (2015 and 2016)
Table Spain Peptide Therapeutics Market Share by Application (2015 and 2016)
Figure Benelux Peptide Therapeutics Sales and Growth Rate (2011-2016)
Figure Benelux Peptide Therapeutics Revenue and Growth Rate (2011-2016)
Figure Benelux Peptide Therapeutics Sales Price Trend (2011-2016)
Table Benelux Peptide Therapeutics Sales by Manufacturers (2015 and 2016)
Table Benelux Peptide Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Benelux Peptide Therapeutics Sales by Type (2015 and 2016)
Table Benelux Peptide Therapeutics Market Share by Type (2015 and 2016)
Table Benelux Peptide Therapeutics Sales by Application (2015 and 2016)
Table Benelux Peptide Therapeutics Market Share by Application (2015 and 2016)
Table Peptide Therapeutics Basic Information List
Table Amgen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Peptide Therapeutics Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Peptide Therapeutics Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Peptide Therapeutics Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Peptide Therapeutics Sales Market Share (2011-2016)
Table Lonza Basic Information List
Table Lonza Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Peptide Therapeutics Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Peptide Therapeutics Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Peptide Therapeutics Sales Market Share (2011-2016)
Table Bachem Basic Information List
Table Bachem Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bachem Peptide Therapeutics Sales Market Share (2011-2016)
Table CordenPharma Basic Information List
Table CordenPharma Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table CordenPharma Peptide Therapeutics Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Peptide Therapeutics Sales Market Share (2011-2016)
Table Ipsen Basic Information List
Table Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ipsen Peptide Therapeutics Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Peptide Therapeutics Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Peptide Therapeutics Sales Market Share (2011-2016)
Table PolyPeptide Group Basic Information List
Table PolyPeptide Group Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table PolyPeptide Group Peptide Therapeutics Sales Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Peptide Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Therapeutics
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Peptide Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2015
Table Major Buyers of Peptide Therapeutics
Table Distributors/Traders List
Figure Germany Peptide Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Germany Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure France Peptide Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure France Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure UK Peptide Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure UK Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Peptide Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Russia Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Peptide Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Italy Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Peptide Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Spain Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Peptide Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Peptide Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table Europe Peptide Therapeutics Sales Forecast by Type (2016-2021)
Table Europe Peptide Therapeutics Sales Forecast by Application (2016-2021)